HYPR News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

HY

Volume

540.39K

Next Earnings

November 9th

Loading chart

HY

HYPRHyperfine, Inc. Class A Common Stock

HYPR

Pay with—

Available Balance0.00

HY

Mkt Cap

$82.7M

Volume

540.39K

Next Earnings

November 9th

Chart Financials Earnings News About Insider Filings

How Decentralized AI is Unlocking Value in Cardiac DiagnosticsFive companies—VentriPoint Diagnostics, HeartBeam, Heartflow, Hyperfine, and GE Healthcare Technologies—are advancing AI-enabled cardiac diagnostic platforms to address the global heart disease crisis. Recent developments include VentriPoint's partnership with First Light Health for remote Indigenous communities, HeartBeam's collaboration with Mount Sinai on AI-ECG algorithms, Heartflow's new clinical registry data, Hyperfine's breakthrough stroke detection results, and GE Healthcare's role in the EU's COMPASS cardiotoxicity initiative.Benzinga · Mar 27, 2026

Bedside Breakthrough: AI Brings MRI-Precision to Every ClinicAI-driven clinical intelligence is transforming medical imaging, with point-of-care diagnostics projected to reach $70.92 billion by 2032. The CMS ACCESS Model launching in July 2026 will reward outcome-based care, driving adoption of software-defined imaging platforms. Key players including VentriPoint Diagnostics, Butterfly Network, Hyperfine, Hologic, and GE HealthCare are advancing portable, AI-powered diagnostic solutions that deliver hospital-grade precision at the bedside, reducing facility overhead while improving patient outcomes.Benzinga · Jan 16, 2026

Hyperfine Q2 Revenue Jumps 26 PercentHyperfine reported Q2 2025 results with $2.7 million revenue, 26% sequential increase, and eight system sales. The company achieved FDA clearances, expanded gross margins to 49.3%, and reduced cash burn by 19%, projecting 10-20% revenue growth for the year.The Motley Fool · Aug 14, 2025

Hyperfine (HYPR) to Release ACTION PMR Study Data for Swoop - Zacks Investment ResearchHyperfine's Swoop system has shown promising results in a study on its ability to quickly assess stroke patients and guide treatment decisions. The study, part of the larger ACTION PMR study, found the Swoop system to be a reliable tool for enabling critical stroke treatment choices in urgent care settings.Zacks Investment Research · Jul 16, 2024

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/ETap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These are Vita Coco Company (COCO), AMC Entertainment (AMC), Hyperfine (HYPR), Aptevo Therapeutics (APVO) and CLEAR Secure (YOU).Zacks Investment Research · May 28, 2024

Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue EstimatesHyperfine (HYPR) delivered earnings and revenue surprises of 0% and 8.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 13, 2024

Hyperfine, Inc. Reports First Quarter 2024 Financial ResultsGUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2024 financial results and provided a business update.GlobeNewswire Inc. · May 13, 2024

Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should KnowHyperfine (HYPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.Zacks Investment Research · May 6, 2024

Down -19% in 4 Weeks, Here's Why Hyperfine (HYPR) Looks Ripe for a TurnaroundHyperfine (HYPR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.Zacks Investment Research · Apr 25, 2024

Hyperfine, Inc. (HYPR) Reports Q4 Loss, Lags Revenue EstimatesHyperfine (HYPR) delivered earnings and revenue surprises of 11.76% and 26.61%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Mar 21, 2024

to start trading

HY

HYPRHyperfine, Inc. Class A Common Stock

HYPR

Pay with—

Available Balance0.00

Your PositionYou don't own any HYPR yet.

Related Tickers

Earnings